Recent studies have found that psilocybin, the naturally occurring chemical in psychoactive mushrooms, may help those suffering from depression and anxiety. Is it time to rethink our approach to psychedelic substances?
Policy based on common assumptions and popular sentiments can become a recipe for mistaken prescriptions and misguided interventions. Nowhere is this divorce between rhetoric and reality more evident than in the formulation of global drug policies.
The former secretary of state is once again coming under fire for using the word "super-predators."
The reasons that drugs like heroin, cocaine, marijuana and others are illegal today have far more to do with economics and cultural prejudice than with addiction.
In the War on Drugs no one really wins. Even drug traffickers with all their riches kill each other off. For these reasons and more, the possibility of global drug reform represented by April's special United Nation's session on the topic symbolizes hope for many people.
It's a rare day when the prohibitionist establishment and die-hard drug policy reformers are in agreement -- but that happens to be the case more often than not when it comes to what the U.S. insists on calling "synthetic drugs."
The drug war is the U.S.' most failed social policy intervention in modern history -- yet the call to rethink its assumptions, and revise our approach to regulation of illicit drugs, has been issued and seriously engaged only by reformers in Europe and Latin America.
Long story short, when thinking about prison reform, stakeholders need to consider the needs of the many, not the few. Reforms should be applicable to most prisoners, not solely first-time, non-violent drug offenders.